Ally Bridge Group »

Insmed shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.8M 250k 27.13

More positions owned by Ally Bridge Group

Blueprint Medicines (BPMC)
Soleno Therapeutics (SLNO)
Cg Oncology
Xenon Pharmaceuticals (XENE)
Verona Pharma Sponsored Ads (VRNA)
Merus N V (MRUS)
Praxis Precision Medicines I (PRAX)
Mind Medicine Mindmed Com New (MNMD)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Geron Corporation (GERN)
Jasper Therapeutics Com New (JSPR)
Kura Oncology (KURA)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Olema Pharmaceuticals (OLMA)

View all positions for Ally Bridge Group

Top funds holding Insmed

Vanguard Group
BlackRock
T. Rowe Price Associates
FMR
State Street Corporation
Deep Track Capital
Palo Alto Investors
William Blair Investment Management
Macquarie Group
Franklin Resources
T. Rowe Price Investment Management
Geode Capital Management
Ameriprise Financial
Henderson Group
Alliancebernstein

View all funds holding Insmed